According to an in vivo investigation on mice, it has been found that decreased expression of KLF14 expression up-regulates the pre-adipocyte proliferation and interrupts normal lipogenesis, which results in the progression of T2DM, dyslipidemia, and insulin resistance. Here, KLF14 is linked to metabolic syndrome.